|
|
|
|
| LEADER |
01662nam a2200337 a 4500 |
| 001 |
c000174407 |
| 003 |
CARM |
| 005 |
20041025113126.0 |
| 008 |
790809s1979 ne a b 101 0 eng |
| 010 |
|
|
|a 79019489
|
| 019 |
1 |
|
|a 1490782
|5 LACONCORD2021
|
| 020 |
|
|
|a 0444801332
|
| 035 |
|
|
|a (OCoLC)5333874
|5 LACONCORD2021
|
| 040 |
|
|
|a LC
|b eng
|c LC
|d LC
|
| 050 |
0 |
0 |
|a RC270
|b .W67 1978
|
| 082 |
0 |
0 |
|a 616.9/94/075
|
| 111 |
2 |
|
|a Workshop on Tumour Markers,
|n 3rd :
|d 1978 :
|c Lunteren
|
| 245 |
1 |
0 |
|a Tumour markers, impact and prospects /
|c Workshop on Tumour Markers, fundamental aspects and clinical evaluation, held in Lunteren, The Netherlands, on December 12-14, 1978 ; organized under the auspices of the Scientific Council of the Netherlands Cancer Society (Koningin Wilhelmina Fonds) ; editors, E. Boelsma, Ph. Rümke.
|
| 260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier/North-Holland Biomedical Press ;
|a New York :
|b sole distributors for the USA and Canada, Elsevier North Holland,
|c 1979.
|
| 300 |
|
|
|a viii, 338 p. :
|b ill. ;
|c 25 cm.
|
| 440 |
|
0 |
|a Applied methods in oncology ;
|v v. 2
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Tumors
|x Diagnosis
|x Congresses.
|
| 650 |
|
0 |
|a Tumor markers
|x Analysis
|x Congresses.
|
| 650 |
|
0 |
|a Tumor antigens
|x Analysis
|x Congresses.
|
| 700 |
1 |
|
|a Boelsma, E.
|
| 700 |
1 |
|
|a Rümke, Ph.
|q (Philip)
|
| 710 |
2 |
|
|a Koningin Wilhelmina Fonds.
|b Scientific Council.
|
| 852 |
8 |
|
|b CARM
|h A2:AN10F0
|i C06222
|p 0244776
|f BK
|
| 999 |
f |
f |
|i fdc9328e-fc93-5889-b9c8-2f0b6ac24118
|s 6a87bdb7-8e7d-5d08-ba93-ab476b0f4521
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|e C06222
|f A2:AN10F0
|h Other scheme
|i book
|m 0244776
|